Literature DB >> 17719276

Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis.

Lisa Goldsack1, Joanna R Kirman.   

Abstract

Efforts to develop a new, more effective vaccine for tuberculosis have been hampered by a lack of understanding of what constitutes a protective memory immune response. While interferon gamma production by CD4(+) T cells after vaccination is commonly used as a surrogate of protective memory immunity, its use in this regard appears to have little predictive value. We argue that this is due to the different requirements for interferon gamma-mediated protection in the primary response versus the memory recall response. In this review, we present evidence that suggests memory CD4(+) T cells can protect against tuberculosis in the absence of interferon gamma, and discuss potential mechanisms that may be involved such as IL-17 and regulatory T cells. A comprehensive understanding of the requirements for protective memory immunity to tuberculosis is essential for the development of an effective vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719276     DOI: 10.1016/j.tube.2007.07.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  38 in total

1.  Editorial: Be careful what you ask for: is the presence of IL-17 indicative of immunity?

Authors:  Andrea M Cooper
Journal:  J Leukoc Biol       Date:  2010-08       Impact factor: 4.962

Review 2.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

3.  Lactation-Based Maternal Educational Immunity Crosses MHC Class I Barriers and Can Impart Th1 Immunity to Th2-Biased Recipients.

Authors:  Mrinal K Ghosh; H Konrad Muller; Ameae M Walker
Journal:  J Immunol       Date:  2017-07-26       Impact factor: 5.422

4.  Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.

Authors:  Mark T Orr; Hillarie Plessner Windish; Elyse A Beebe; David Argilla; Po-Wei D Huang; Valerie A Reese; Steven G Reed; Rhea N Coler
Journal:  J Infect Dis       Date:  2015-01-30       Impact factor: 5.226

5.  Incubation of whole blood at 39°C augments gamma interferon (IFN-γ)-induced protein 10 and IFN-γ responses to Mycobacterium tuberculosis antigens.

Authors:  Martine G Aabye; Pernille Ravn; Isik S Johansen; Jesper Eugen-Olsen; Morten Ruhwald
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

6.  Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice.

Authors:  Markus Haug; Jane A Awuh; Magnus Steigedal; June Frengen Kojen; Anne Marstad; Ivar S Nordrum; Øyvind Halaas; Trude H Flo
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

7.  TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4.

Authors:  Toshihiro Ito; Matthew Schaller; Cory M Hogaboam; Theodore J Standiford; Matyas Sandor; Nicholas W Lukacs; Stephen W Chensue; Steven L Kunkel
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

8.  Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment.

Authors:  James M Young; Ifedayo M O Adetifa; Martin O C Ota; Jayne S Sutherland
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

9.  Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.

Authors:  Jayne S Sutherland; Bouke C de Jong; David J Jeffries; Ifedayo M Adetifa; Martin O C Ota
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

Review 10.  Th17 cells: a new fate for differentiating helper T cells.

Authors:  Zhi Chen; John J O'Shea
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.